Data Foundry

Drug recalls 2015

Propofol Injectable Emulsion — Class II drug recall D-0381-2015

Terminated recall by Hospira Inc., reported 2015-02-04, distributed nationwide. Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vi

Recall numberD-0381-2015
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., Lake Forest, IL, United States
Recall initiated2014-12-23
Classified2015-01-27
Reported by FDA2015-02-04
Terminated2015-07-30
DistributedNationwide (US)
Quantity126,075 vials
Reason classesspecification failure
NDC00409-0010, 00409-0010-97, 00409-0010-98, 00409-0501, 00409-0501-97, 00409-0501-98, 00409-1511, 00409-1511-97, 00409-1511-98, 00409-4699, 00409-4699-24, 00409-4699-30, 00409-4699-33, 00409-4699-50, 00409-4699-53, 00409-4699-54, 00409-6010, 00409-6010-02, 00409-6010-25
Lot numbers35-844-DJ
Expiration dates2015-11-01

Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, Contains Benzyl Alcohol, For I.V. Administration, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30

Reason for recall

Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0381-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.